Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | OT |
No additional AE; a missed dose of GARDASIL 9; This spontaneous report was received from a Consumer o and refers to a 33-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 01-Oct-2024, the patient received the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) (strength, formulation, dose, route, lot # and expiration date were not reported) for prophylaxis. The patient missed following doses (Inappropriate schedule of product administration). No adverse event was reported.